Monthly Archives: December 2013

Seed-led venture creation is our focus at Atlas, and, with the closing of our new fund, 2013 has been a very active year for us.  As part of a year-end reflection, it’s a good opportunity to present a quick sketch

The past year has certainly been the most exciting one for Biotech IPOs since 2000, with dozens of new offerings and compelling therapeutic narratives.  But focusing on these new IPOs misses an equal if not more exciting story: the significant

In the tech-dominated venture capital world, 2013 could be called the year of the crowd.  With the JOBS Act and the emergence of credible platforms like AngelList, crowdfunding has come into the mainstream in a meaningful way. Social media, software,